SlideShare a Scribd company logo
1 of 60
Nancy Gómez Usuga Residente de Anestesiología U de A
Epidemiología ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],EPIDEMIOLOGÍA
Epidemiología ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Factores de riesgo ,[object Object],[object Object],FACTORES DE RIESGO
Epidemiología ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],EPIDEMIOLOGÍA
Epidemiología ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],EPIDEMIOLOGÍA
Epidemiología ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],EPIDEMIOLOGÍA
[object Object],[object Object],[object Object],[object Object],[object Object],Neuroanestesia. Cap 12. 2005 British Journal of Anaesthesia 99 (1): 102–18 (2007 FISIOPATOLOGÍA
[object Object],[object Object],[object Object],[object Object],British Journal of Anaesthesia 99 (1): 102–18 (2007 FISIOPATOLOGÍA
British Journal of Anaesthesia 99 (1): 102–18 (2007 100 200 Normotenso HTA cronica Increasing risk of  hypertensive encephalopathy Increasing risk  of ischemia 50 150 250  Pacientes con isquemia cerebral pierden la autorregulación Falla autorregulación Cerebral Blood Flow MAP (mm Hg)
Diagnóstico Clínico ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],DIAGNÓSTICO CLÍNICO
Clasificación  Hunt y Hess CLASIFICACIÓN  HUNT  Y  HESS HTA, DM, EPOC, arterioesclerosis grave, vasoespasmo angiográfico
Presión Intracraneana PIC mmHg 30 20 10 0 I - II II- III III- IV
CLASIFICACIÓN FEDERACIÓN MUNDIAL  DE NEUROCIRUJANOS
FISIOPATOLOGÍA 5% 10-20%
Diagnóstico Radiológico ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
DIAGNÓSTICO ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],S  77-97% E 87-100%
CLASIFICACIÓN FISHER
Complicaciones ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Anesthesiology Clin N Am 2002; 20: 377–388 COMPLICACIONES
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Anesthesiology Clin N Am 2002; 20: 377–388 RESANGRADO
RESANGRADO Y VASOESPASMO  DESPUÉS DE HSA 4 – 3 – 2 – 1 – 0 – Vasoespasmo  sintomático Resangrado I I I I I I I I I I I I 0 1 2  3 4 5  6   7 8 9 10 11 12 Días después de HSA %  probabilidad
[object Object],[object Object],[object Object],[object Object],Mayberg MR, et al.  Circulation . 1994;90:2592-2605.  Anesthesiology Clin N Am 2002; 20: 377–388 N Engl J Med 2006;354:387-96. PREVENCIÓN DE RESANGRADO EN HSA
Neurosurg Rev (2006) 29: 179–193 VASOESPASMO CEREBRAL
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Anesthesiology Clin N Am 2002; 20: 377–388 VASOESPASMO CEREBRAL Veloc promedio  ACM > 120 cm/seg
Profilaxis Vasoespasmo ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],PROFILAXIS VASOESPASMO
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],TRATAMIENTO VASOESPASMO
Terapia Triple H ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],TERAPIA TRIPLE H
[object Object],[object Object],[object Object],[object Object],TERAPIA TRIPLE H
[object Object],[object Object],[object Object],Crit Care Med 2006 , 34: 511-524 Terapia triple H: Nivel de evidencia Clase Indeterminada. TERAPIA TRIPLE H
[object Object],[object Object],[object Object],[object Object],[object Object],Anesthesiology Clin N Am 2002; 20: 377–388 HIPERTENSIÓN ENDOCRANEANA
[object Object],[object Object],[object Object],[object Object],SINDROME CONVULSIVO
ALTERACIONES DEL SODIO ↓ Mantener  EUVOLEMIA ↓ ↑ OK,  ↑ ↓ Na VOLUMEN TTO CAUSA SIADH OK,  ↑ Restringir líquidos ADH Cerebro perdedor de sal ↓ ↓ SSN  o hipertónica Fludrocortisona PNA y C Diabetes insípida -  Poliuria Vasopresina dosis ? ADH
EPIDEMIOLOGÍA  Riesgo de ruptura a 5 años ,[object Object],< 7 mm 7-12 mm 13-24 mm > 24 mm CoA 0 2.6% 14.5% 40% Cerebral anterior 0 2.6% 14.5% 40% Carótida interna 0 2.6% 14.5% 40% CoP 2.5% 14.5% 18.5% 50% Cir.  posterior 2.5% 14.5% 18.5% 50%
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],N Engl J Med 2006;354:387-96 . MANEJO INVASIVO
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],TRATAMIENTO ENDOVASCULAR
VALORACIÓN PREANESTÉSICA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Anesthesiology Clin N Am 2002; 20: 377–388
VALORACIÓN PREANESTÉSICA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Anesthesiology Clin N Am 2002; 20: 377–388
HLG Anemia, leucocitosis TP, TPT Coagulopatía BUN, creatinina, electrolitos HipoMg: Pobre descenlace HipoNa Glicemia Pobre descenlace Rayos X tórax Edema pulmonar, aspiración ECG 12 derivaciones ST, arritmias TAC AngioTAC
Manejo Anestésico ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Tratamiento  Medidas generales  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],N Engl J Med 2006;354:387-96.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],PPC  =  PAM  -  PIC  ( 95 - 20  mmHg) PTM =  PAM  -  PIC  (  95 - 20  mmHg)  INDUCCIÓN ANESTÉSICA
POSICIÓN ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Manejo Anestésico
ANESTÉSICOS AGENTE CMO 2 FSC PIC PAM NEUROPROTECCIÓN PROPOFOL ↓ ↓  ↓ ↓ ↓ ???? BARBITÚRICOS ↓ 50% ↓ ↓ ↓   Ago GABA. Requiere admon. pre-isquemia y corto tiempo de isquemia. Antagonistas NMDA  Ketamina,  Xenón, óxido nitroso. ↑  = ↑  50% ↑  = ↑  = Regulacion Ca-glutamato. Pre-acondicioamiento. Dosis??? Nivel evidencia 7-8. Indeterminada. ETOMIDATO ↓ ↓ ↓ = ????
ANESTÉSICOS
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Anesthesiology Clin N Am 2002; 20: 377–388 MANTENIMIENTO
Los anestésicos volátiles ( > 1 MAC) deterioran la autorregulación en un grado dependiente de la dosis.  Después de 2-5 horas de administración continua, el FSC comienza a retornar al VN. ANESTÉSICOS
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],RELAJACIÓN CEREBRAL
[object Object],[object Object],[object Object],[object Object],[object Object],RELAJACIÓN CEREBRAL
MANEJO ANESTÉSICO ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Crit Care Med 2006 , 34: 511-524
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],RUPTURA INTRAOPERATORIA
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],En general el paciente debe salir como entro al quirófano, con excepciones Anesthesiology Clin N Am 2002; 20: 377–388 DESPERTAR
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Neuroanestesia. Cap 12. 2005 DESPERTAR
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],EMBARAZO
CUIDADOS FETALES PERIPARTO ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
EMBARAZO Y NEUROANESTESIA Idealmente equipo multidisciplinario Terapia anticonvulsivate Profilaxis aspiración Administración de oxígeno Plan manejo de vía aérea Inducción secuencia rápida a partir segundo trimestre Evitar compresión aorto-cava
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],EMBARAZO Y NEUROANESTESIA CONSIDERACIONES HEMODINÁMICAS MANEJO VENTILATORIO
EMBARAZO Y NEUROANESTESIA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
EMBARAZO Y NEUROANESTESIA TIVA vs Balanceada Relajante despolarizante vs no despolarizante Opioide  Sulfato de Mg IV: 30- 60 mg/Kg Evitar óxido nitroso Oxitocina Metergina
EMBARAZO Y NEUROANESTESIA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MANEJO DEL DOLOR PROFILAXIS TVP
 

More Related Content

What's hot

Anestesia En CirugíA OtorrinolaringolóGica
Anestesia En CirugíA OtorrinolaringolóGicaAnestesia En CirugíA OtorrinolaringolóGica
Anestesia En CirugíA OtorrinolaringolóGicaguest8decbd
 
Anestesia para el paciente quemado
Anestesia para el paciente quemadoAnestesia para el paciente quemado
Anestesia para el paciente quemadoanestesiahsb
 
Anestesia pediatrica
Anestesia pediatricaAnestesia pediatrica
Anestesia pediatricakoki castro
 
Profundidad anestesica final
Profundidad anestesica finalProfundidad anestesica final
Profundidad anestesica finalanestesiahsb
 
425761165 bloqueo-caudal
425761165 bloqueo-caudal425761165 bloqueo-caudal
425761165 bloqueo-caudalRodrigoBenet1
 
Anestesia para cirugía de hipófisis
Anestesia para cirugía de hipófisisAnestesia para cirugía de hipófisis
Anestesia para cirugía de hipófisisSocundianeste
 
Caso clínico analgesia en craneotomía
Caso clínico analgesia en craneotomíaCaso clínico analgesia en craneotomía
Caso clínico analgesia en craneotomíaSocundianeste
 
Ventilacion mecanica en el paciente neurocrítico
Ventilacion mecanica en el paciente neurocríticoVentilacion mecanica en el paciente neurocrítico
Ventilacion mecanica en el paciente neurocríticoNilia Yoly Abad Quispe
 
Anestesia en cirugía de cuello
Anestesia en cirugía de cuelloAnestesia en cirugía de cuello
Anestesia en cirugía de cuelloJulioAguinaga
 

What's hot (20)

Analgesia Epidural
Analgesia EpiduralAnalgesia Epidural
Analgesia Epidural
 
Anestesia En CirugíA OtorrinolaringolóGica
Anestesia En CirugíA OtorrinolaringolóGicaAnestesia En CirugíA OtorrinolaringolóGica
Anestesia En CirugíA OtorrinolaringolóGica
 
Anestesia para el paciente quemado
Anestesia para el paciente quemadoAnestesia para el paciente quemado
Anestesia para el paciente quemado
 
Anestesia raquidea
Anestesia raquideaAnestesia raquidea
Anestesia raquidea
 
Extubacion Traqueal
Extubacion TraquealExtubacion Traqueal
Extubacion Traqueal
 
Bloqueo caudal
Bloqueo caudalBloqueo caudal
Bloqueo caudal
 
Anestesia para cirugía de tórax
Anestesia para cirugía de tóraxAnestesia para cirugía de tórax
Anestesia para cirugía de tórax
 
Dexmedetomidina
DexmedetomidinaDexmedetomidina
Dexmedetomidina
 
Anestesia pediatrica
Anestesia pediatricaAnestesia pediatrica
Anestesia pediatrica
 
Profundidad anestesica final
Profundidad anestesica finalProfundidad anestesica final
Profundidad anestesica final
 
425761165 bloqueo-caudal
425761165 bloqueo-caudal425761165 bloqueo-caudal
425761165 bloqueo-caudal
 
Anestesia total intravenosa (TIVA)
Anestesia total intravenosa (TIVA)Anestesia total intravenosa (TIVA)
Anestesia total intravenosa (TIVA)
 
Bloqueo peridural.
Bloqueo peridural.Bloqueo peridural.
Bloqueo peridural.
 
Anestesia para cirugía de hipófisis
Anestesia para cirugía de hipófisisAnestesia para cirugía de hipófisis
Anestesia para cirugía de hipófisis
 
Caso clínico analgesia en craneotomía
Caso clínico analgesia en craneotomíaCaso clínico analgesia en craneotomía
Caso clínico analgesia en craneotomía
 
Valvulopatias en Anestesia
Valvulopatias en AnestesiaValvulopatias en Anestesia
Valvulopatias en Anestesia
 
Anestesia para cirugía de tórax
Anestesia para cirugía de tóraxAnestesia para cirugía de tórax
Anestesia para cirugía de tórax
 
Ventilacion mecanica en el paciente neurocrítico
Ventilacion mecanica en el paciente neurocríticoVentilacion mecanica en el paciente neurocrítico
Ventilacion mecanica en el paciente neurocrítico
 
4. VIA AEREA Y ANESTESIA
4. VIA AEREA Y ANESTESIA4. VIA AEREA Y ANESTESIA
4. VIA AEREA Y ANESTESIA
 
Anestesia en cirugía de cuello
Anestesia en cirugía de cuelloAnestesia en cirugía de cuello
Anestesia en cirugía de cuello
 

Viewers also liked

Aneurisma cerebral
Aneurisma cerebralAneurisma cerebral
Aneurisma cerebralAna Ortiz C
 
HEMORRAGIA SUBARACNOIDEA: Vasoespasmo e isquemia cerebral tardia
HEMORRAGIA SUBARACNOIDEA: Vasoespasmo e isquemia cerebral tardiaHEMORRAGIA SUBARACNOIDEA: Vasoespasmo e isquemia cerebral tardia
HEMORRAGIA SUBARACNOIDEA: Vasoespasmo e isquemia cerebral tardiaNilia Yoly Abad Quispe
 
Aneurisma Cerebral
Aneurisma CerebralAneurisma Cerebral
Aneurisma Cerebralguest8decbd
 
Fisiopatologia de Sepsis y choque séptico
Fisiopatologia de Sepsis y choque sépticoFisiopatologia de Sepsis y choque séptico
Fisiopatologia de Sepsis y choque sépticoLeon Vargas
 
Hemorragia subaracnoideas - Aneurisma cerebral
Hemorragia subaracnoideas - Aneurisma cerebralHemorragia subaracnoideas - Aneurisma cerebral
Hemorragia subaracnoideas - Aneurisma cerebraladnmedicina
 
Aneurisma Cerebral
Aneurisma CerebralAneurisma Cerebral
Aneurisma CerebralPauKilljoy
 
Aneurisma Intracraneal: Asesino Silencioso - Final
Aneurisma Intracraneal: Asesino Silencioso - FinalAneurisma Intracraneal: Asesino Silencioso - Final
Aneurisma Intracraneal: Asesino Silencioso - Finalmauroestuvoaqui
 
Manejo Anestesico De La Paciente Gestante Con Cardiopatía
Manejo Anestesico De La Paciente Gestante Con CardiopatíaManejo Anestesico De La Paciente Gestante Con Cardiopatía
Manejo Anestesico De La Paciente Gestante Con Cardiopatíaguestc3bf72
 
Sepsis y Anestesiólogo
Sepsis y AnestesiólogoSepsis y Anestesiólogo
Sepsis y Anestesiólogohadoken Boveri
 
Aneurismas cerebrales
Aneurismas cerebralesAneurismas cerebrales
Aneurismas cerebralesKathy Moreno
 
Anaesthesia for interventional neuroradiology
Anaesthesia for interventional neuroradiologyAnaesthesia for interventional neuroradiology
Anaesthesia for interventional neuroradiologyDr Kumar
 
Capitulo 61 flujo sanguíneo cerebral
Capitulo 61 flujo sanguíneo cerebralCapitulo 61 flujo sanguíneo cerebral
Capitulo 61 flujo sanguíneo cerebralEnehidy Cazares
 
Vasoespasmo arterial cerebral. Fundamentos.
Vasoespasmo arterial cerebral. Fundamentos.Vasoespasmo arterial cerebral. Fundamentos.
Vasoespasmo arterial cerebral. Fundamentos.Arturo Ayala-Arcipreste
 
Muerte cerebral
Muerte cerebralMuerte cerebral
Muerte cerebralyilupinan
 
Cuantas "H" en el tratamiento del vasoespasmo?
Cuantas "H" en el tratamiento del vasoespasmo?Cuantas "H" en el tratamiento del vasoespasmo?
Cuantas "H" en el tratamiento del vasoespasmo?goeding
 

Viewers also liked (20)

Aneurisma cerebral
Aneurisma cerebralAneurisma cerebral
Aneurisma cerebral
 
HEMORRAGIA SUBARACNOIDEA: Vasoespasmo e isquemia cerebral tardia
HEMORRAGIA SUBARACNOIDEA: Vasoespasmo e isquemia cerebral tardiaHEMORRAGIA SUBARACNOIDEA: Vasoespasmo e isquemia cerebral tardia
HEMORRAGIA SUBARACNOIDEA: Vasoespasmo e isquemia cerebral tardia
 
Aneurisma Cerebral
Aneurisma CerebralAneurisma Cerebral
Aneurisma Cerebral
 
Fisiopatologia de Sepsis y choque séptico
Fisiopatologia de Sepsis y choque sépticoFisiopatologia de Sepsis y choque séptico
Fisiopatologia de Sepsis y choque séptico
 
Hemorragia subaracnoideas - Aneurisma cerebral
Hemorragia subaracnoideas - Aneurisma cerebralHemorragia subaracnoideas - Aneurisma cerebral
Hemorragia subaracnoideas - Aneurisma cerebral
 
Seminario aaa
Seminario aaaSeminario aaa
Seminario aaa
 
Aneurisma Cerebral
Aneurisma CerebralAneurisma Cerebral
Aneurisma Cerebral
 
Jornadas 2006
Jornadas 2006Jornadas 2006
Jornadas 2006
 
Aneurisma Intracraneal: Asesino Silencioso - Final
Aneurisma Intracraneal: Asesino Silencioso - FinalAneurisma Intracraneal: Asesino Silencioso - Final
Aneurisma Intracraneal: Asesino Silencioso - Final
 
Manejo Anestesico De La Paciente Gestante Con Cardiopatía
Manejo Anestesico De La Paciente Gestante Con CardiopatíaManejo Anestesico De La Paciente Gestante Con Cardiopatía
Manejo Anestesico De La Paciente Gestante Con Cardiopatía
 
Sepsis y Anestesiólogo
Sepsis y AnestesiólogoSepsis y Anestesiólogo
Sepsis y Anestesiólogo
 
Aneurismas cerebrales
Aneurismas cerebralesAneurismas cerebrales
Aneurismas cerebrales
 
Anaesthesia for interventional neuroradiology
Anaesthesia for interventional neuroradiologyAnaesthesia for interventional neuroradiology
Anaesthesia for interventional neuroradiology
 
Capitulo 61 flujo sanguíneo cerebral
Capitulo 61 flujo sanguíneo cerebralCapitulo 61 flujo sanguíneo cerebral
Capitulo 61 flujo sanguíneo cerebral
 
Aneurismas
AneurismasAneurismas
Aneurismas
 
Aneurisma abdominal roto
Aneurisma abdominal rotoAneurisma abdominal roto
Aneurisma abdominal roto
 
Vasoespasmo arterial cerebral. Fundamentos.
Vasoespasmo arterial cerebral. Fundamentos.Vasoespasmo arterial cerebral. Fundamentos.
Vasoespasmo arterial cerebral. Fundamentos.
 
Neurocx vasoespasmo
Neurocx   vasoespasmoNeurocx   vasoespasmo
Neurocx vasoespasmo
 
Muerte cerebral
Muerte cerebralMuerte cerebral
Muerte cerebral
 
Cuantas "H" en el tratamiento del vasoespasmo?
Cuantas "H" en el tratamiento del vasoespasmo?Cuantas "H" en el tratamiento del vasoespasmo?
Cuantas "H" en el tratamiento del vasoespasmo?
 

Similar to HSA Factores Riesgo Epidemiología

Trujillo Jueves, Hemorragia Subaracnoidea
Trujillo Jueves, Hemorragia SubaracnoideaTrujillo Jueves, Hemorragia Subaracnoidea
Trujillo Jueves, Hemorragia SubaracnoideaLuis Vargas
 
Simposio Hipertensión Arterial - Círculos en fisiopatología en la hipertensió...
Simposio Hipertensión Arterial - Círculos en fisiopatología en la hipertensió...Simposio Hipertensión Arterial - Círculos en fisiopatología en la hipertensió...
Simposio Hipertensión Arterial - Círculos en fisiopatología en la hipertensió...Conferencia Sindrome Metabolico
 
Hemorragia subaracnoidea
Hemorragia subaracnoideaHemorragia subaracnoidea
Hemorragia subaracnoideaLidsay Uh
 
24-11-10
24-11-1024-11-10
24-11-10nachirc
 
Hipertensión arterial secundaria
Hipertensión arterial secundariaHipertensión arterial secundaria
Hipertensión arterial secundariaJose Pinto Llerena
 
Enfermedad cerebro vascular
Enfermedad cerebro vascular Enfermedad cerebro vascular
Enfermedad cerebro vascular valisanmartin
 
Manejo del Ataque cerebrovascular isquémico agudo
Manejo del Ataque cerebrovascular isquémico agudoManejo del Ataque cerebrovascular isquémico agudo
Manejo del Ataque cerebrovascular isquémico agudoAlvaro Soto Venegas
 
DR. MAICOL AUGUSTO CORTEZ SANDOVAL /Falla cardiaca cronica/HOSPITAL NACIONAL ...
DR. MAICOL AUGUSTO CORTEZ SANDOVAL /Falla cardiaca cronica/HOSPITAL NACIONAL ...DR. MAICOL AUGUSTO CORTEZ SANDOVAL /Falla cardiaca cronica/HOSPITAL NACIONAL ...
DR. MAICOL AUGUSTO CORTEZ SANDOVAL /Falla cardiaca cronica/HOSPITAL NACIONAL ...MAICOL AUGUSTO
 

Similar to HSA Factores Riesgo Epidemiología (20)

aneusrisma cerebral
aneusrisma cerebralaneusrisma cerebral
aneusrisma cerebral
 
Ecv
EcvEcv
Ecv
 
Trujillo Jueves, Hemorragia Subaracnoidea
Trujillo Jueves, Hemorragia SubaracnoideaTrujillo Jueves, Hemorragia Subaracnoidea
Trujillo Jueves, Hemorragia Subaracnoidea
 
Simposio Hipertensión Arterial - Círculos en fisiopatología en la hipertensió...
Simposio Hipertensión Arterial - Círculos en fisiopatología en la hipertensió...Simposio Hipertensión Arterial - Círculos en fisiopatología en la hipertensió...
Simposio Hipertensión Arterial - Círculos en fisiopatología en la hipertensió...
 
Hemorragia subaracnoidea
Hemorragia subaracnoideaHemorragia subaracnoidea
Hemorragia subaracnoidea
 
24-11-10
24-11-1024-11-10
24-11-10
 
Hipertensión arterial secundaria
Hipertensión arterial secundariaHipertensión arterial secundaria
Hipertensión arterial secundaria
 
Ave En Urgencia
Ave En UrgenciaAve En Urgencia
Ave En Urgencia
 
Acv Isquemico.
Acv Isquemico.Acv Isquemico.
Acv Isquemico.
 
Dr. Azpitarte Almagro: Caso clínico con insuficiencia renal
Dr. Azpitarte Almagro: Caso clínico con insuficiencia renalDr. Azpitarte Almagro: Caso clínico con insuficiencia renal
Dr. Azpitarte Almagro: Caso clínico con insuficiencia renal
 
HTA.ppt
HTA.pptHTA.ppt
HTA.ppt
 
Accidente Vascular Encefálico
Accidente Vascular EncefálicoAccidente Vascular Encefálico
Accidente Vascular Encefálico
 
Enfermedad cerebro vascular
Enfermedad cerebro vascular Enfermedad cerebro vascular
Enfermedad cerebro vascular
 
Anestesia en cirugías de carótida
Anestesia en cirugías de carótida Anestesia en cirugías de carótida
Anestesia en cirugías de carótida
 
ETEV para MIR.pptx
ETEV para MIR.pptxETEV para MIR.pptx
ETEV para MIR.pptx
 
Coloquio ecv
Coloquio ecvColoquio ecv
Coloquio ecv
 
Coartacion aortica
Coartacion aorticaCoartacion aortica
Coartacion aortica
 
Manejo del Ataque cerebrovascular isquémico agudo
Manejo del Ataque cerebrovascular isquémico agudoManejo del Ataque cerebrovascular isquémico agudo
Manejo del Ataque cerebrovascular isquémico agudo
 
Neurointervencionismo
NeurointervencionismoNeurointervencionismo
Neurointervencionismo
 
DR. MAICOL AUGUSTO CORTEZ SANDOVAL /Falla cardiaca cronica/HOSPITAL NACIONAL ...
DR. MAICOL AUGUSTO CORTEZ SANDOVAL /Falla cardiaca cronica/HOSPITAL NACIONAL ...DR. MAICOL AUGUSTO CORTEZ SANDOVAL /Falla cardiaca cronica/HOSPITAL NACIONAL ...
DR. MAICOL AUGUSTO CORTEZ SANDOVAL /Falla cardiaca cronica/HOSPITAL NACIONAL ...
 

More from anestesiologia

paciente Neurocrítico
paciente Neurocríticopaciente Neurocrítico
paciente Neurocríticoanestesiologia
 
trauma craneo encefalico
trauma craneo encefalicotrauma craneo encefalico
trauma craneo encefalicoanestesiologia
 
neurofisiología y anestesia
neurofisiología y anestesianeurofisiología y anestesia
neurofisiología y anestesiaanestesiologia
 
Diabetes y anestesia 2010 junio
Diabetes y anestesia 2010 junioDiabetes y anestesia 2010 junio
Diabetes y anestesia 2010 junioanestesiologia
 
Intercambiadores de tuboendotraqueal
Intercambiadores de tuboendotraquealIntercambiadores de tuboendotraqueal
Intercambiadores de tuboendotraquealanestesiologia
 
EvaluacióN De La VíA AéRea2 Copia
EvaluacióN De La VíA AéRea2   CopiaEvaluacióN De La VíA AéRea2   Copia
EvaluacióN De La VíA AéRea2 Copiaanestesiologia
 
Anestesia En Trauma Encefalocraneano
Anestesia En Trauma EncefalocraneanoAnestesia En Trauma Encefalocraneano
Anestesia En Trauma Encefalocraneanoanestesiologia
 
recostruccion 3D fracturas mandibulares
recostruccion 3D fracturas mandibularesrecostruccion 3D fracturas mandibulares
recostruccion 3D fracturas mandibularesanestesiologia
 
Anestesia En Trasplante HepáTico
Anestesia En Trasplante HepáTicoAnestesia En Trasplante HepáTico
Anestesia En Trasplante HepáTicoanestesiologia
 
Anestesia En Trasplante HepáTico
Anestesia En Trasplante HepáTicoAnestesia En Trasplante HepáTico
Anestesia En Trasplante HepáTicoanestesiologia
 
Cardiopatia Congenita en el embarazo
Cardiopatia Congenita en el embarazoCardiopatia Congenita en el embarazo
Cardiopatia Congenita en el embarazoanestesiologia
 
Caso Clinico ReseccióN Traqueal
Caso Clinico  ReseccióN TraquealCaso Clinico  ReseccióN Traqueal
Caso Clinico ReseccióN Traquealanestesiologia
 

More from anestesiologia (20)

Trauma Raqui-medular
Trauma Raqui-medularTrauma Raqui-medular
Trauma Raqui-medular
 
trauma raquimedular
trauma raquimedulartrauma raquimedular
trauma raquimedular
 
paciente Neurocrítico
paciente Neurocríticopaciente Neurocrítico
paciente Neurocrítico
 
trauma craneo encefalico
trauma craneo encefalicotrauma craneo encefalico
trauma craneo encefalico
 
neurointervencionismo
neurointervencionismoneurointervencionismo
neurointervencionismo
 
neurofisiología y anestesia
neurofisiología y anestesianeurofisiología y anestesia
neurofisiología y anestesia
 
enfermedad carotidea
enfermedad carotideaenfermedad carotidea
enfermedad carotidea
 
Diabetes y anestesia 2010 junio
Diabetes y anestesia 2010 junioDiabetes y anestesia 2010 junio
Diabetes y anestesia 2010 junio
 
Intercambiadores de tuboendotraqueal
Intercambiadores de tuboendotraquealIntercambiadores de tuboendotraqueal
Intercambiadores de tuboendotraqueal
 
EvaluacióN De La VíA AéRea2 Copia
EvaluacióN De La VíA AéRea2   CopiaEvaluacióN De La VíA AéRea2   Copia
EvaluacióN De La VíA AéRea2 Copia
 
Capnografia
CapnografiaCapnografia
Capnografia
 
Anestesia En Trauma Encefalocraneano
Anestesia En Trauma EncefalocraneanoAnestesia En Trauma Encefalocraneano
Anestesia En Trauma Encefalocraneano
 
recostruccion 3D fracturas mandibulares
recostruccion 3D fracturas mandibularesrecostruccion 3D fracturas mandibulares
recostruccion 3D fracturas mandibulares
 
Urgencias Neonatales
Urgencias NeonatalesUrgencias Neonatales
Urgencias Neonatales
 
Anestesia En Trasplante HepáTico
Anestesia En Trasplante HepáTicoAnestesia En Trasplante HepáTico
Anestesia En Trasplante HepáTico
 
Anestesia En Trasplante HepáTico
Anestesia En Trasplante HepáTicoAnestesia En Trasplante HepáTico
Anestesia En Trasplante HepáTico
 
Aines Y Anestesia
Aines Y AnestesiaAines Y Anestesia
Aines Y Anestesia
 
Cardiopatia Congenita en el embarazo
Cardiopatia Congenita en el embarazoCardiopatia Congenita en el embarazo
Cardiopatia Congenita en el embarazo
 
Caso Clinico ReseccióN Traqueal
Caso Clinico  ReseccióN TraquealCaso Clinico  ReseccióN Traqueal
Caso Clinico ReseccióN Traqueal
 
DERIVACIÓN SUBMENTAL
DERIVACIÓN SUBMENTALDERIVACIÓN SUBMENTAL
DERIVACIÓN SUBMENTAL
 

Recently uploaded

TEST DE RAVEN es un test conocido para la personalidad.pdf
TEST DE RAVEN es un test conocido para la personalidad.pdfTEST DE RAVEN es un test conocido para la personalidad.pdf
TEST DE RAVEN es un test conocido para la personalidad.pdfDannyTola1
 
Fundamentos y Principios de Psicopedagogía..pdf
Fundamentos y Principios de Psicopedagogía..pdfFundamentos y Principios de Psicopedagogía..pdf
Fundamentos y Principios de Psicopedagogía..pdfsamyarrocha1
 
TUTORIA II - CIRCULO DORADO UNIVERSIDAD CESAR VALLEJO
TUTORIA II - CIRCULO DORADO UNIVERSIDAD CESAR VALLEJOTUTORIA II - CIRCULO DORADO UNIVERSIDAD CESAR VALLEJO
TUTORIA II - CIRCULO DORADO UNIVERSIDAD CESAR VALLEJOweislaco
 
FICHA DE MONITOREO Y ACOMPAÑAMIENTO 2024 MINEDU
FICHA DE MONITOREO Y ACOMPAÑAMIENTO  2024 MINEDUFICHA DE MONITOREO Y ACOMPAÑAMIENTO  2024 MINEDU
FICHA DE MONITOREO Y ACOMPAÑAMIENTO 2024 MINEDUgustavorojas179704
 
5° SEM29 CRONOGRAMA PLANEACIÓN DOCENTE DARUKEL 23-24.pdf
5° SEM29 CRONOGRAMA PLANEACIÓN DOCENTE DARUKEL 23-24.pdf5° SEM29 CRONOGRAMA PLANEACIÓN DOCENTE DARUKEL 23-24.pdf
5° SEM29 CRONOGRAMA PLANEACIÓN DOCENTE DARUKEL 23-24.pdfOswaldoGonzalezCruz
 
periodico mural y sus partes y caracteristicas
periodico mural y sus partes y caracteristicasperiodico mural y sus partes y caracteristicas
periodico mural y sus partes y caracteristicas123yudy
 
ÉTICA, NATURALEZA Y SOCIEDADES_3RO_3ER TRIMESTRE.pdf
ÉTICA, NATURALEZA Y SOCIEDADES_3RO_3ER TRIMESTRE.pdfÉTICA, NATURALEZA Y SOCIEDADES_3RO_3ER TRIMESTRE.pdf
ÉTICA, NATURALEZA Y SOCIEDADES_3RO_3ER TRIMESTRE.pdfluisantoniocruzcorte1
 
Plan Año Escolar Año Escolar 2023-2024. MPPE
Plan Año Escolar Año Escolar 2023-2024. MPPEPlan Año Escolar Año Escolar 2023-2024. MPPE
Plan Año Escolar Año Escolar 2023-2024. MPPELaura Chacón
 
Fisiologia.Articular. 3 Kapandji.6a.Ed.pdf
Fisiologia.Articular. 3 Kapandji.6a.Ed.pdfFisiologia.Articular. 3 Kapandji.6a.Ed.pdf
Fisiologia.Articular. 3 Kapandji.6a.Ed.pdfcoloncopias5
 
SINTAXIS DE LA ORACIÓN SIMPLE 2023-2024.pptx
SINTAXIS DE LA ORACIÓN SIMPLE 2023-2024.pptxSINTAXIS DE LA ORACIÓN SIMPLE 2023-2024.pptx
SINTAXIS DE LA ORACIÓN SIMPLE 2023-2024.pptxlclcarmen
 
Día de la Madre Tierra-1.pdf día mundial
Día de la Madre Tierra-1.pdf día mundialDía de la Madre Tierra-1.pdf día mundial
Día de la Madre Tierra-1.pdf día mundialpatriciaines1993
 
DECÁGOLO DEL GENERAL ELOY ALFARO DELGADO
DECÁGOLO DEL GENERAL ELOY ALFARO DELGADODECÁGOLO DEL GENERAL ELOY ALFARO DELGADO
DECÁGOLO DEL GENERAL ELOY ALFARO DELGADOJosé Luis Palma
 
PPT GESTIÓN ESCOLAR 2024 Comités y Compromisos.pptx
PPT GESTIÓN ESCOLAR 2024 Comités y Compromisos.pptxPPT GESTIÓN ESCOLAR 2024 Comités y Compromisos.pptx
PPT GESTIÓN ESCOLAR 2024 Comités y Compromisos.pptxOscarEduardoSanchezC
 
TRIPTICO-SISTEMA-MUSCULAR. PARA NIÑOS DE PRIMARIA
TRIPTICO-SISTEMA-MUSCULAR. PARA NIÑOS DE PRIMARIATRIPTICO-SISTEMA-MUSCULAR. PARA NIÑOS DE PRIMARIA
TRIPTICO-SISTEMA-MUSCULAR. PARA NIÑOS DE PRIMARIAAbelardoVelaAlbrecht1
 
Estrategias de enseñanza - aprendizaje. Seminario de Tecnologia..pptx.pdf
Estrategias de enseñanza - aprendizaje. Seminario de Tecnologia..pptx.pdfEstrategias de enseñanza - aprendizaje. Seminario de Tecnologia..pptx.pdf
Estrategias de enseñanza - aprendizaje. Seminario de Tecnologia..pptx.pdfAlfredoRamirez953210
 
CIENCIAS NATURALES 4 TO ambientes .docx
CIENCIAS NATURALES 4 TO  ambientes .docxCIENCIAS NATURALES 4 TO  ambientes .docx
CIENCIAS NATURALES 4 TO ambientes .docxAgustinaNuez21
 
Tarea 5-Selección de herramientas digitales-Carol Eraso.pdf
Tarea 5-Selección de herramientas digitales-Carol Eraso.pdfTarea 5-Selección de herramientas digitales-Carol Eraso.pdf
Tarea 5-Selección de herramientas digitales-Carol Eraso.pdfCarol Andrea Eraso Guerrero
 

Recently uploaded (20)

TEST DE RAVEN es un test conocido para la personalidad.pdf
TEST DE RAVEN es un test conocido para la personalidad.pdfTEST DE RAVEN es un test conocido para la personalidad.pdf
TEST DE RAVEN es un test conocido para la personalidad.pdf
 
Fundamentos y Principios de Psicopedagogía..pdf
Fundamentos y Principios de Psicopedagogía..pdfFundamentos y Principios de Psicopedagogía..pdf
Fundamentos y Principios de Psicopedagogía..pdf
 
TUTORIA II - CIRCULO DORADO UNIVERSIDAD CESAR VALLEJO
TUTORIA II - CIRCULO DORADO UNIVERSIDAD CESAR VALLEJOTUTORIA II - CIRCULO DORADO UNIVERSIDAD CESAR VALLEJO
TUTORIA II - CIRCULO DORADO UNIVERSIDAD CESAR VALLEJO
 
FICHA DE MONITOREO Y ACOMPAÑAMIENTO 2024 MINEDU
FICHA DE MONITOREO Y ACOMPAÑAMIENTO  2024 MINEDUFICHA DE MONITOREO Y ACOMPAÑAMIENTO  2024 MINEDU
FICHA DE MONITOREO Y ACOMPAÑAMIENTO 2024 MINEDU
 
5° SEM29 CRONOGRAMA PLANEACIÓN DOCENTE DARUKEL 23-24.pdf
5° SEM29 CRONOGRAMA PLANEACIÓN DOCENTE DARUKEL 23-24.pdf5° SEM29 CRONOGRAMA PLANEACIÓN DOCENTE DARUKEL 23-24.pdf
5° SEM29 CRONOGRAMA PLANEACIÓN DOCENTE DARUKEL 23-24.pdf
 
periodico mural y sus partes y caracteristicas
periodico mural y sus partes y caracteristicasperiodico mural y sus partes y caracteristicas
periodico mural y sus partes y caracteristicas
 
ÉTICA, NATURALEZA Y SOCIEDADES_3RO_3ER TRIMESTRE.pdf
ÉTICA, NATURALEZA Y SOCIEDADES_3RO_3ER TRIMESTRE.pdfÉTICA, NATURALEZA Y SOCIEDADES_3RO_3ER TRIMESTRE.pdf
ÉTICA, NATURALEZA Y SOCIEDADES_3RO_3ER TRIMESTRE.pdf
 
Plan Año Escolar Año Escolar 2023-2024. MPPE
Plan Año Escolar Año Escolar 2023-2024. MPPEPlan Año Escolar Año Escolar 2023-2024. MPPE
Plan Año Escolar Año Escolar 2023-2024. MPPE
 
Unidad 3 | Teorías de la Comunicación | MCDI
Unidad 3 | Teorías de la Comunicación | MCDIUnidad 3 | Teorías de la Comunicación | MCDI
Unidad 3 | Teorías de la Comunicación | MCDI
 
Fisiologia.Articular. 3 Kapandji.6a.Ed.pdf
Fisiologia.Articular. 3 Kapandji.6a.Ed.pdfFisiologia.Articular. 3 Kapandji.6a.Ed.pdf
Fisiologia.Articular. 3 Kapandji.6a.Ed.pdf
 
SINTAXIS DE LA ORACIÓN SIMPLE 2023-2024.pptx
SINTAXIS DE LA ORACIÓN SIMPLE 2023-2024.pptxSINTAXIS DE LA ORACIÓN SIMPLE 2023-2024.pptx
SINTAXIS DE LA ORACIÓN SIMPLE 2023-2024.pptx
 
Día de la Madre Tierra-1.pdf día mundial
Día de la Madre Tierra-1.pdf día mundialDía de la Madre Tierra-1.pdf día mundial
Día de la Madre Tierra-1.pdf día mundial
 
DECÁGOLO DEL GENERAL ELOY ALFARO DELGADO
DECÁGOLO DEL GENERAL ELOY ALFARO DELGADODECÁGOLO DEL GENERAL ELOY ALFARO DELGADO
DECÁGOLO DEL GENERAL ELOY ALFARO DELGADO
 
TL/CNL – 2.ª FASE .
TL/CNL – 2.ª FASE                       .TL/CNL – 2.ª FASE                       .
TL/CNL – 2.ª FASE .
 
PPT GESTIÓN ESCOLAR 2024 Comités y Compromisos.pptx
PPT GESTIÓN ESCOLAR 2024 Comités y Compromisos.pptxPPT GESTIÓN ESCOLAR 2024 Comités y Compromisos.pptx
PPT GESTIÓN ESCOLAR 2024 Comités y Compromisos.pptx
 
TRIPTICO-SISTEMA-MUSCULAR. PARA NIÑOS DE PRIMARIA
TRIPTICO-SISTEMA-MUSCULAR. PARA NIÑOS DE PRIMARIATRIPTICO-SISTEMA-MUSCULAR. PARA NIÑOS DE PRIMARIA
TRIPTICO-SISTEMA-MUSCULAR. PARA NIÑOS DE PRIMARIA
 
Estrategias de enseñanza - aprendizaje. Seminario de Tecnologia..pptx.pdf
Estrategias de enseñanza - aprendizaje. Seminario de Tecnologia..pptx.pdfEstrategias de enseñanza - aprendizaje. Seminario de Tecnologia..pptx.pdf
Estrategias de enseñanza - aprendizaje. Seminario de Tecnologia..pptx.pdf
 
DIA INTERNACIONAL DAS FLORESTAS .
DIA INTERNACIONAL DAS FLORESTAS         .DIA INTERNACIONAL DAS FLORESTAS         .
DIA INTERNACIONAL DAS FLORESTAS .
 
CIENCIAS NATURALES 4 TO ambientes .docx
CIENCIAS NATURALES 4 TO  ambientes .docxCIENCIAS NATURALES 4 TO  ambientes .docx
CIENCIAS NATURALES 4 TO ambientes .docx
 
Tarea 5-Selección de herramientas digitales-Carol Eraso.pdf
Tarea 5-Selección de herramientas digitales-Carol Eraso.pdfTarea 5-Selección de herramientas digitales-Carol Eraso.pdf
Tarea 5-Selección de herramientas digitales-Carol Eraso.pdf
 

HSA Factores Riesgo Epidemiología

  • 1. Nancy Gómez Usuga Residente de Anestesiología U de A
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9. British Journal of Anaesthesia 99 (1): 102–18 (2007 100 200 Normotenso HTA cronica Increasing risk of hypertensive encephalopathy Increasing risk of ischemia 50 150 250 Pacientes con isquemia cerebral pierden la autorregulación Falla autorregulación Cerebral Blood Flow MAP (mm Hg)
  • 10.
  • 11. Clasificación Hunt y Hess CLASIFICACIÓN HUNT Y HESS HTA, DM, EPOC, arterioesclerosis grave, vasoespasmo angiográfico
  • 12. Presión Intracraneana PIC mmHg 30 20 10 0 I - II II- III III- IV
  • 15.
  • 16.
  • 18.
  • 19.
  • 20. RESANGRADO Y VASOESPASMO DESPUÉS DE HSA 4 – 3 – 2 – 1 – 0 – Vasoespasmo sintomático Resangrado I I I I I I I I I I I I 0 1 2 3 4 5 6 7 8 9 10 11 12 Días después de HSA % probabilidad
  • 21.
  • 22. Neurosurg Rev (2006) 29: 179–193 VASOESPASMO CEREBRAL
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31. ALTERACIONES DEL SODIO ↓ Mantener EUVOLEMIA ↓ ↑ OK, ↑ ↓ Na VOLUMEN TTO CAUSA SIADH OK, ↑ Restringir líquidos ADH Cerebro perdedor de sal ↓ ↓ SSN o hipertónica Fludrocortisona PNA y C Diabetes insípida - Poliuria Vasopresina dosis ? ADH
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37. HLG Anemia, leucocitosis TP, TPT Coagulopatía BUN, creatinina, electrolitos HipoMg: Pobre descenlace HipoNa Glicemia Pobre descenlace Rayos X tórax Edema pulmonar, aspiración ECG 12 derivaciones ST, arritmias TAC AngioTAC
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43. ANESTÉSICOS AGENTE CMO 2 FSC PIC PAM NEUROPROTECCIÓN PROPOFOL ↓ ↓ ↓ ↓ ↓ ???? BARBITÚRICOS ↓ 50% ↓ ↓ ↓ Ago GABA. Requiere admon. pre-isquemia y corto tiempo de isquemia. Antagonistas NMDA Ketamina, Xenón, óxido nitroso. ↑ = ↑ 50% ↑ = ↑ = Regulacion Ca-glutamato. Pre-acondicioamiento. Dosis??? Nivel evidencia 7-8. Indeterminada. ETOMIDATO ↓ ↓ ↓ = ????
  • 45.
  • 46. Los anestésicos volátiles ( > 1 MAC) deterioran la autorregulación en un grado dependiente de la dosis. Después de 2-5 horas de administración continua, el FSC comienza a retornar al VN. ANESTÉSICOS
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55. EMBARAZO Y NEUROANESTESIA Idealmente equipo multidisciplinario Terapia anticonvulsivate Profilaxis aspiración Administración de oxígeno Plan manejo de vía aérea Inducción secuencia rápida a partir segundo trimestre Evitar compresión aorto-cava
  • 56.
  • 57.
  • 58. EMBARAZO Y NEUROANESTESIA TIVA vs Balanceada Relajante despolarizante vs no despolarizante Opioide Sulfato de Mg IV: 30- 60 mg/Kg Evitar óxido nitroso Oxitocina Metergina
  • 59.
  • 60.  

Editor's Notes

  1. Nontraumatic subarachnoid hemorrhage is a neurologic emergency characterized by the extravasation of blood into the spaces covering the central nervous system that are filled with cerebrospinal fluid. The leading cause of nontraumatic subarachnoid hemorrhage is rupture of an intracranial aneurysm, which accounts for about 80 percent of cases and has a high rate of death and complications.1 Nonaneurysmal subarachnoid hemorrhage, including isolated perimesencephalic subarachnoid hemorrhage, occurs in about 20 percent of cases and carries a good prognosis with uncommon neurologic complications.2 This review focuses on aneurysmal subarachnoid hemorrhage. As many as 46 percent of survivors of subarachnoid hemorrhage may have long-term cognitive impairment, with an effect on functional status and quality of life.3,4 The disorder is also associated with a substantial burden on health care resources, most of which are related to hospitalization.5. It accounts for 2 to 5 percent of all new strokes and affects 21,000 to 33,000 people each year in the United States.6-8 The incidence of the disorder has remained stable over the past 30 years,1 and although it varies from region to region, the aggregate worldwide incidence is about 10.5 cases per 100,000 person-years.9
  2. The major identified modifiable risk factors include cigarette smoking, hypertension, cocaine use, and heavy alcohol use.20-22 Patients with a family history of first-degree relatives with subarachnoid hemorrhage are also at a higher risk.21,23 Heritable connective-tissue disorders associated with the presence of intracranial polycystic kidney disease, the Ehlers–Danlos syndrome (type IV), pseudoxanthoma elasticum, and fibromuscular dysplasia
  3. A marked difference in fatality rates—for example ranging between China/Beijing and Russia/Moscow from 23% (95% CI 13–23) to 51% (95% CI 42–60)—may indicate the importance of medical management and treatment. Once an aneurysm has ruptured, treatment is focussed on the prevention of re-bleeding and prevention of secondary injury from ischaemia (vasospasm).
  4. The major factors associated with poor outcome are the patient’s level of consciousness on admission, age, and the amount of blood shown by initial computed tomography (CT) of the head. Several grading systems are used to assess the initial clinical and radiologic features of subarachnoid hemorrhage. The two most widely used clinical scales are those of Hunt and Hess and the World Federation of Neurological Surgeons. The latter is currently preferred since it is based on the sum score of the Glasgow Coma Scale (a very reliable method for evaluating the level of consciousness) and the presence of focal neurologic signs. The higher the score, the worse the prognosis. The amount of blood seen on initial head CT scanning can be easily evaluated. A thick subarachnoid clot and bilateral ventricular hemorrhage are both predictive of poor outcome and can be reliably graded on head CT.
  5. Dilataciones arteriales anormales por debilidad de la capa elástica arterial; frecuentemente en bifurcaciones por turbulencia de flujo sanguíneo
  6. Autoregulation refers to the inherent regulation of arterial diameter to allow maintenance of a relatively constant amount of blood flow in different vascular beds and is most frequently discussed in terms of cerebral tissue. 1 Autoregulation is lost in ischemic tissue. In patients with chronic hypertension, the structure of the arterioles thickens and entire autoregulatory curve is shifted to the right. When BP is increased beyond the upper limits of autoregulation, “breakthrough” hyperperfusion occurs. In previously normotensive patients, whose vessels have not been altered by prior exposure to high pressures, breakthrough typically occurs at a MAP of about 120 mm Hg. In chronic hypertensive patients, the breakthrough may occur at 160 mm Hg. 2 As such, a normotensive patient would be expected to develop end-organ damage at a lower BP than a chronic hypertensive. Lowering BP into the normal range in a poorly controlled, chronic hypertensive patient may actually accelerate end-organ damage. 2 1. Berne RM, Levy MN. Cardiovascular Physiology . 8th ed. Philadelphia, Pa: Mosby; 2001. 2. Strandgaard S. Circulation . 1976;53:720-727.
  7. Subarachnoid hemorrhage should always be suspected in patients with a typical presentation which includes a sudden onset of severe headache (frequently described as the “worst ever”), with nausea, vomiting, neck pain, photophobia, and loss of consciousness. Physical examination may reveal retinal hemorrhages, meningismus, a diminished level of consciousness, and localizing neurologic signs. The latter finding usually includes third-nerve palsy (posterior communicating aneurysm), sixth-nerve palsy (increased intracranial pressure), bilateral lower-extremity weakness or abulia (anterior communicating aneurysm), and the combination of hemiparesis and aphasia or visuospatial neglect (middle cerebral-artery aneurysm). Retinal hemorrhages should be differentiated from the preretinal hemorrhages of Terson’s syndrome, which indicates a more abrupt increase in intracranial pressure and increased mortality.
  8. Patients with Hess and Hunt grade I and II (Table 1) are likely to have normal ICP and preserved cerebrovascular reactivity; thus, they can be expected to respond to hyperventilation with cerebral vasoconstriction. In contrast, patients with Hess and Hunt grade III and IV are likely to have increased ICP and impaired cerebrovascular reactivity; hyperventilation is thus unlikely to result in reliable cerebral vasoconstriction. A low Glasgow Coma Scale score (8) is usually associated with increased ICP.
  9. The latter is currently preferred since it is based on the sum score of the Glasgow Coma Scale (a very reliable method for evaluating the level of consciousness) and the presence of focal neurologic signs. The higher the score, the worse the prognosis. The amount of blood seen on initial head CT scanning can be easily evaluated
  10. Head CT scanning should be the first study performed in any patient with suspected subarachnoid hemorrhage. The characteristic appearance of extravasated blood is hyperdense. Since small amounts of blood can be missed, all scans should be performed with thin cuts through the base of the brain. Because of rapid clearance of blood, delayed head CT scanning may be normal despite a suggestive history, and sensitivity drops to 50 percent at seven days. Head CT scanning can also demonstrate intraparenchymal hematomas, hydrocephalus, and cerebral edema and can help predict the site of aneurysm rupture, particularly in patients with aneurysms in the anterior cerebral or anterior communicating arteries. Head CT scanning is also the most reliable test for predicting cerebral vasospasm and poor outcome.
  11. Rebleeding occurs most comonly during the first 24 hours following initial SAH. Recurrent aneurysmal hemorrhage is a devastating complication associated with increased morbidity and mortality. Because of the incidence of rebleeding with conservative management of SAH, early aneurysm clipping (days 0–3) is currently recommended for patients who are alert on admission
  12. The daily percentage probability for the development of symptomatic vasospasm or re-bleeding after subarachnoid hemorrhage. Day 0 denotes onset of subarachnoid hemorrhage.
  13. Hypertension is a common risk factor for hemorrhagic stroke and increases the risk of serious complications if not effectively controlled during the early post-event phases. It is logical to conclude that elevated or rapidly changing blood pressure may increase the likelihood of rebleeding following subarachnoid hemorrhage. However, no clear benefit of antihypertensive therapy to reduce the incidence of rebleed in has been established. As a result, no specific antihypertensive recommendations were made in the 1994 Guidelines.
  14. Angiographic vasospasm is defined as a narrowing of the contrast medium column in major cerebral arteries. Clinical vasospasm is defined as the ischaemic consequences of cerebral vasospasm resulting in various degrees of neurological deficits.
  15. Cerebral vasopasm is a major cause of morbidity and mortality in SAH patients Angiographic evidence of vasospasm can be detected in up to 70% of patients. However, clinical vasospasm with ischemic deficits is observed in approximately 30% of patients, most often between days 4–12, with a peak at 6–7 days following SAH [10]. The diagnosis of vasospasm is confirmed by angiography. The transcranial Doppler (TCD) is a safe, repeatable, noninvasive method to identify and quantify vasospasm, and can be used to evaluate the effectiveness of various therapies. The mechanism responsible for vasospasm is unknown; however, structural and pathologic changes have been demonstrated in the vessel wall. There is also evidence that vasospasm after SAH correlates with the amount of blood in the subarachnoid space, and removal of extravasated blood decreases the occurrence and severity of ischemic deficits. The component in blood implicated in causing cerebral arterial vasospasm is oxyhemoglobin. Another method for treating symptomatic vasospasm is cerebral angioplasty. Transluminal angioplasty can be used to dilate constricted major cerebral vessels in patients refractory to conventional treatmen These procedures are usually performed under general anesthesia to minimize movement and permit accurate placement of the intraarterial balloon used to dilate the cerebral vessels. The risks of angioplasty include aneurysm rupture, intimal dissection, vessel rupture, ischemia, and infarction
  16. Comment. Hypovolemia and hypotension after aSAH are strongly linked to adverse outcome and should be avoided in all patients. The existing data do not support the prophylactic use of triple-H therapy in patients with aSAH who do not have clinical evidence of vasospasm. In patients with symptomatic vasospasm,hemodynamic augmentation may reverse neurologic deterioration; however, an adequately powered randomized trial is needed to test the hypothesis that triple-H therapy has a favorable effect on neurologic outcomes or survival and is safe when compared with a strategy of normovolemia and normotension. Further study is needed to better understand the effects of increased cardiac output, as opposed to hypertensive therapy, on CBF and on the reversal of symptomatic vasospasm. At this time, TBA and intraarterial vasodilators administration are reasonable options in treating vasospasm refractory to medical management. However,the relative efficacy and harm of TBA vs.medical management needs further substantiation. This might take the form of a randomized trial comparing immediateangioplasty vs. triple-H therapy in patients who have developed symptomatic vasospasm. In patients with symptomatic vasospasm in whom triple-H therapy and endovascular options have either failed or are contraindicated, consideration should be given to IABC or to neuroprotective interventions such therapeutic hypothermia and pentobarbital coma (see below).
  17. The therapeutic goal of triple-H therapy is to increase CBF, increase CPP, and improve the rheological blood characteristics. For this purpose, systolic arterial pressure is increased (by administration of i.v. fluid or cardiovasoactive drugs) to approximately 120–150 mm Hg in unclipped and 160–200 mm Hg in clipped aneurysms; central venous pressure is maintained at 8–12 mm Hg (or pulmonary artery wedge pressure at 15–18 mm Hg); and haematocrit is decreased to approximately 0.3–0.35. Most
  18. Intacranial hypertension is present to some degree in most patients following a SAH. Intracranial pressure gradually returns to normal by the end of the first week. If an intracerebral hemorrhage, intraventricular hemorrhage, vasospasm, or hydrocephalus develops, intracranial hypertension may be severe and require treatment. Patients may require emergency ventriculostomy, steroids, diuretics, or intubation and hyperventilation. ICP should be lowered gradually, especially in patients with unclipped aneurysms . Abrupt lowering of ICP by lumbar puncture, ventricular drainage, or rapid infusion of mannitol can induce rebleeding .
  19. The risk of rupture depends on the size and location of the aneurysm. According to an international study of unruptured intracranial aneurysms, in patients with no history of subarachnoid hemorrhage, the five-year cumulative rate of rupture of aneurysms located in the internal carotid artery, anterior communicating artery, anterior cerebral artery, or middle cerebral artery is zero for aneurysms under 7 mm, 2.6 percent for 7 to 12 mm, 14.5 percent for 13 to 24 mm, and 40 percent for 25 mm or more. This rate is in contrast to rupture rates of 2.5 percent, 14.5 percent, 18.4 percent, and 50 percent, respectively, for the same sizes of aneurysms in the posterior circulating and posterior communicating artery
  20. In general, elderly patients or patients in poor medical condition are often better suited for endovascular coiling. Aneurysms of the vertebrobasilar circulation or aneurysms deep in the skull base, such as paraophthalmic aneurysms, may be more easily accessed by an endovascular approach.
  21. Currently, the two main therapeutic options for securing a ruptured aneurysm are microvascular neurosurgical clipping and endovascular coiling. Historically, microsurgical clipping has been the preferred method of treatment. Although the timing of surgery has been debated, most neurovascular surgeons recommend early operation. Evi 46,47 The authors found that for this particular subgroup of patients, a favorable outcome, which was defined as survival free of disability at one year, occurred significantly more often in patients treated with endovascular coiling than with surgical placement of clips. The risk of epilepsy was substantially lower in patients who underwent endovascular coiling, but the risk of rebleeding was higher. Also, in patients who underwent follow-up cerebral angiography, the rate of complete occlusion of the aneurysm was greater with surgical clipping. In general, elderly patients or patients in poor medical condition are often better suited for endovascular coiling. Aneurysms of the vertebrobasilar circulation or aneurysms deep in the skull base, such as paraophthalmic aneurysms, may be more easily accessed by an endovascular approach.
  22. Electrolyte abnormalities frequently occur secondary to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion or diabetes insipidus. Hyponatremia is the most common electrolyte disturbance detected, and is often associated with a high urinary sodium and osmolality, which is expected with SIADH. Unlike a patient with SIADH, however, the patient with SAH usually has a contracted intravascular volume despite hyponatremia. This cerebral saltwasting syndrome may be caused by release of an atrial natriuretic factor from the damaged brain. The recommended therapy is to maintain normovolemia with isotonic saline solutions. Other factors contributing to intravascular volume contraction in these patients are supine diuresis secondary to increased thoracic blood volume, negative nitrogen balance, decreased erythropoiesis, increased catecholamine levels, and iatrogenic blood loss. Fluid balance and electrolyte abnormalities should be corrected prior to surgery. Electrocardiographic abnormalities are commonly associated with ruptured cerebral aneurysms [25]. The ECG changes include ST-segment depression or elevation, T-wave inversion or flattening, U-waves, prolonged Q-T intervals, and dysrhythmia. The ECG changes are not necessarily associated with increased operative morbidity and mortality or consistent increases in serum myoglobin or creatine kinase. They usually resolve within 10 days following SAH, and require no special treatment. When indicated, cardiac troponin-I levels should be drawn to determine the clinical significance of these abnormalities [26]. When cardiac dysrhythmia and occasional frank subendocardial ischemia result in cardiac failure, appropriate treatment must be instituted. ECG abnormalities (e.g. QTc prolongation, repolarization abnormalities) have been reported in 25–100% of cases,40 101 123 along with an increase in serum concentration of cardiac troponin in 17–28% and of creatine kinase MB isoenzyme in 37%,11 22 109 123 and left ventricular dysfunction in 8–30% of cases.20 47 124 The most severe form of cardiac injury associated with SAH is the syndrome of neurogenic-stunned myocardium, which is characterized by reversible left ventricular systolic dysfunction, cardiogenic shock, and pulmonary oedema.46
  23. The anesthetic goals for intracranial aneurysm surgery are to avoid aneurysm rupture, maintain cerebral perfusion pressure and transmural aneurysm pressure, and provide, a ‘‘slack’’ brain. Patients in WFNS scale I or II who appear anxious should receive premedication. Cerebral perfusion pressure (CPP) is maintained by using drugs in doses that avoid sudden or profound decreases in systemic blood pressure or increases in ICP. To minimize the risk of hypertension and aneurysmal rupture during induction of anesthesia, intravenous lidocaine and the beta-adrenergic antagonist (esmolol) or labetalol are recommended. Following induction, ventilation is mechanically controlled to maintain normocarbia, if ICP is normal. If intracranial hypertension is present, the PaC02 is lowered to 30–35 mmHg. A deep plane of anesthesia must be established prior to insertion of head pins, scalp incision, turning the bone flap, and opening the dura to avoid a hypertensive response . When intracranial hypertension is present, anesthesia should be deepened with additional doses of thiopental and fentanyl until the skull is opened. Several techniques can be instituted during aneurysm surgery to provide a ‘‘slack’’ brain and facilitate dissection. These are hyperventilation of the lungs, osmotic diuresis, barbiturate administration, and CSF drainage during the procedure. Controlar gradiente de presión transmural del aneurisma Adecuada PPC y oxigenación Evitar variaciones en PIC Evitar daño secundario Condiciones quirúrgicas Despertar rápido y suave
  24. Blood pressure should be maintained within normal limits, and if necessary, intravenous antihypertensive agents such as labetalol and nicardipine can be used.23 Once the aneurysm is secured, hypertension is allowed, but there is no agreement on the range. Analgesia is often required, and reversible agents such as narcotics are indicated. Two important factors that are associated with poor outcome are hyperglycemia and hyperthermia, and both should be corrected.39,40 Prophylaxis of deep venous thrombosis should be instituted early with sequential compressive devices, and subcutaneous heparin should be added after the aneurysm is treated. Calcium antagonists reduce the risk of poor outcome from ischemic complications, and oral nimodipine is currently recommended.41 Prolonged administration of antifibrinolytic agents reduces rebleeding but is associated with an increased risk of cerebral ischemia and systemic thrombotic events.42 Early treatment of aneurysms has become the mainstay of rebleeding prevention, but antifibrinolytic therapy may be used in the short term before aneurysm treatment.
  25. The two variables that require considerable attention are CPP and TMPG of the aneurysm. CPP is calculated as the difference between mean arterial pressure (MAP) and ICP (CPP¼MAP2ICP). The TMPG of the aneurysm is calculated as the difference between the pressure within the aneurysm (equal to MAP) and the pressure outside the aneurysm (equal to ICP) (TMPG¼MAP2ICP). Thus, TMPG and CPP are governed by the same variables (MAP and ICP). The objectives are to maintain TMPG as low as possible to reduce the risk of aneurysm rupture, and CPP as high as needed to provide adequate cerebral oxygenation. Overall, it seems sensible to maintain blood pressure at preoperative levels until the aneurysm is secured. If treatment of the increased ICP becomes necessary before opening of the dura, such treatment should not be overly aggressive because an abrupt decrease in ICP causes an equally abrupt increase in the TMPG of the aneurysm. Opening of the dura in the presence of markedly elevated ICP may have the same detrimental effect.
  26. Trasnductor en la base del craneo para medir la PPC SVY: aporte y demanda de oxigeno en forma global, invertigación en paciente con HSA Electorencefalograma: permite determinar la tolerancia al pinzamiento y protección cerebral al usar pentotal. Potenciales evocados: funcion neuronal durante el pinzamiento, si aumento tiempo de conduccion o perdida del registro: riesgo de lesion neurológica. Dopler transcraneano: monitoria del FSC durante la anestesia, evalua efecto de hierventilacion, hipotensión y presencia de vasoespasmo
  27. Mantenimiento de la anestesia Cualquier IV (excepto ketamina) Etomidato convulsión Protección del edema cerebral Halogenado subMAC, hiperventilación Control PIC Anticiparse a estímulos dolorosos
  28. Ischaemic preconditioning may be observed in patients with recurrent transient ischaemic attacks.91 Determination of the exact molecular mechanisms involved in ischaemic preconditioning is under active investigation. Depending on the organ and preconditioning stimulus, ischaemic precond itioning may induce tolerance within minutes or days and is effective for hours or days. Rapid ischaemic preconditioning appears to involve activation and phosphorylation of ATPsensitive Kþ channels in cell membranes and inner mitochondrial membranes.92 Delayed preconditioning may result from induced gene expression or protective proteins. Delayed preconditioning in the brain often requires multiple applications of the trigger daily before ischaemia and may protect the brain for a week. Various important pathways have been identified and have been comprehensively reviewed. Studies to determine the relevance of ischaemic preconditioning in humans are difficult to perform, and only two retrospective studies are available suggesting the protection of recurrent transient ischaemic attacks in stroke patients.
  29. Los anestésicos volátiles ( &gt; 1.5 MAC) deterioran la autorregulación en un grado dependiente de la dosis. Después de 2-5 horas de administración continua, el FSC comienza a retornar al VN. Favorecen fenómeno de robo circulatorio. Isoflurano: favorece la absorción de LCR.
  30. deliberate hypotension during aneurysm dissection, the risk-benefit ratio must be assessed for each patient [27]. The potential benefit of hypotension must be weighed against the risk of causing cerebral ischemia or ischemia to other organs. Patients with a history of cardiovascular disease, occlusive cerebrovascular disease, intracerebral hematoma, fever, anemia, and renal disease are not good candidates for induced hypotension. Such patients should only be subjected to moderate reductions in systemic blood pressure (20–30 mmHg), if at all. The most commonly used agents to induce hypotension are sodium nitroprusside, isoflurane, and esmolo temporary clipping [28,29]. The temporary occlusion of a feeding artery produces an acute reduction in focal blood flow and a slack aneurysm, thus eliminating the need for induced hypotension and its systemic effects. Depending on the location of the aneurysm, either somatosensory evoked potentials or brain stem auditory evoked potentials can be used to monitor the safety of temporary occlusion [ When the aneurysm is secured, intraoperative fluid deficits are replaced and additional volume is administered. At the time of aneurysm dissection, blood is available for transfusion in case the aneurysm ruptures. A bolus of thiopental (3–5mgkg1) may be given before temporary occlusion of a major intracranial vessel and before aneurysm clipping. If temporary occlusion lasts longer than 10 minutes, recirculation should be established, and additional thiopental administered before reapplying the temporary clip. Following aneurysm clipping, the central venous pressure and pulmonary capillary wedge pressure are raised to 10–12 mmHg or 12–18 mmHg, respectively, with crystalloid, colloid, or blood. A postoperative hematocrit between 30–35% is desirable.
  31. Causas sistñemicas: hipotermia, hipoglicemia, alteraciones electrolíticas, acidosis, etc.